Suppr超能文献

富含甘油三酯脂蛋白的致动脉粥样硬化性。

Atherogenicity of triglyceride-rich lipoproteins.

作者信息

Krauss R M

机构信息

Donner Laboratory, Lawrence Berkeley National Laboratory, University of California, Berkeley 94720, USA.

出版信息

Am J Cardiol. 1998 Feb 26;81(4A):13B-17B. doi: 10.1016/s0002-9149(98)00032-0.

Abstract

There is increasing evidence that alterations in metabolism of triglyceride-rich lipoproteins are of importance in the pathogenesis of atherosclerosis and its clinical consequences. Particles with the characteristics of triglyceride-rich lipoprotein remnants have been related to the extent and severity of atherosclerosis in humans and in animal models. These particles can be identified using ultracentrifugal procedures as small, very low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL) with Svedberg flotation rates (Sf) of 12-60. Postprandial triglyceride levels also have been related to risk of coronary artery disease, consistent with a pathologic role for remnant lipoproteins. In studies in which measurements of lipoprotein subfractions have been carried out, levels of IDL have been more predictive than low-density lipoprotein (LDL) of atherosclerosis progression as assessed by coronary artery angiography or carotid artery ultrasonography. These findings suggest that a considerable portion of the coronary disease risk attributed to LDL may be accounted for by the IDL particles included in standard LDL measurements. Other metabolic changes associated with increased levels of plasma triglyceride may also adversely affect cardiovascular disease risk. These include reductions in HDL-cholesterol and apoprotein A1, increased levels of small dense LDL particles, redistribution of apoC-III from HDL to apoB-containing lipoproteins, diminished insulin sensitivity, and procoagulant changes, including increased levels of the fibrinolysis inhibitor, plasminogen-activator inhibitor-1 (PAI-1). A predominance of small dense LDL (subclass pattern B) is a discrete marker for this cluster of interrelated abnormalities and is found in 40-50% of patients with coronary artery disease. Therapeutic interventions with favorable effects on components of this dysmetabolic profile appear to be of value in decreasing atherosclerosis risk in a substantial proportion of the population.

摘要

越来越多的证据表明,富含甘油三酯的脂蛋白代谢改变在动脉粥样硬化的发病机制及其临床后果中具有重要意义。具有富含甘油三酯脂蛋白残粒特征的颗粒与人类和动物模型中动脉粥样硬化的程度和严重程度相关。这些颗粒可以通过超速离心法鉴定为小的、极低密度脂蛋白(VLDL)和中间密度脂蛋白(IDL),其斯维德伯格漂浮率(Sf)为12 - 60。餐后甘油三酯水平也与冠状动脉疾病风险相关,这与残粒脂蛋白的病理作用一致。在进行脂蛋白亚组分测量的研究中,通过冠状动脉造影或颈动脉超声评估,IDL水平比低密度脂蛋白(LDL)更能预测动脉粥样硬化的进展。这些发现表明,归因于LDL的相当一部分冠心病风险可能由标准LDL测量中包含的IDL颗粒所导致。与血浆甘油三酯水平升高相关的其他代谢变化也可能对心血管疾病风险产生不利影响。这些变化包括高密度脂蛋白胆固醇和载脂蛋白A1降低、小而密LDL颗粒水平升高、载脂蛋白C-III从HDL重新分布到含载脂蛋白B的脂蛋白、胰岛素敏感性降低以及促凝变化,包括纤溶酶原激活物抑制剂-1(PAI-1)水平升高。小而密LDL(亚类模式B)占优势是这一相互关联异常簇的一个离散标志物,在40% - 50%的冠心病患者中存在。对这种代谢异常谱的成分具有有利影响的治疗干预措施似乎在降低相当一部分人群的动脉粥样硬化风险方面具有价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验